Calycosin attenuates dextran sulfate sodium (DSS)-induced experimental colitis

OBJECTIVE(S): Inflammatory bowel disease (IBD) results from dysregulation of intestinal mucosal immunity. It is an incurable disease that affects millions of people worldwide. Developing new strategies for the treatment of colitis has been a major challenge. Here, we report the effect of calycosin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Liu, Zheng, Pengyuan, Xia, Liu, Yong, Yu, Lu, Gaofeng, Tang, Fuai, Zhao, Zhiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651460/
https://www.ncbi.nlm.nih.gov/pubmed/29085602
http://dx.doi.org/10.22038/IJBMS.2017.9276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651460/
https://www.ncbi.nlm.nih.gov/pubmed/29085602
http://dx.doi.org/10.22038/IJBMS.2017.9276

Ejemplares similares